
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1044 | 954 | 1044 | 989 | 1119 | 1420 |
Fund Return | 4.36% | -4.65% | 4.36% | -0.37% | 2.27% | 3.57% |
Place in category | 665 | 636 | 665 | 351 | - | - |
% in Category | 68 | 65 | 68 | 53 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00B2NLMV86 | 4.76B | 3.16 | 2.37 | 4.49 | ||
IE00B2NLMX01 | 4.76B | 3.45 | 2.16 | 4.15 | ||
IE00B2NLMW93 | 4.76B | 3.11 | 4.07 | 5.50 | ||
IE0004878413 | 2.83B | 30.81 | 9.61 | 10.26 | ||
IE0032082988 | 2.48B | 18.81 | 4.68 | 6.35 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DWS Health Care Typ O NC | 306.49M | 6.01 | -0.21 | 6.34 | ||
apo Medical Opportunities Institut | 22.47M | 2.28 | -1.49 | 6.01 | ||
nova Steady HealthCare I | 7.82M | -6.67 | -13.73 | - | ||
nova Steady HealthCare P | 7.82M | -7.24 | -14.25 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.00 | 920.63 | +1.71% | |
UnitedHealth | US91324P1021 | 6.63 | 474.96 | +1.37% | |
Novo Nordisk B | DK0062498333 | 5.27 | 644.5 | +0.42% | |
iShares Healthcare Innovation Acc | IE00BYZK4776 | 4.97 | 7.410 | -1.46% | |
Merck&Co | US58933Y1055 | 4.52 | 92.25 | +1.84% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Strong Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | BUY |
Summary | Strong Buy | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review